Sponsor:
Duke University
Code:
NCT06575712
Conditions
Hematopoietic Stem Cell Transplant
CAR-T Cell Therapy
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Step Up
Usual Care Plus (UC+)
Brief summary:
Conditions
Hematopoietic Stem Cell Transplant
CAR-T Cell Therapy
Study ID
NCT06575712
Start date
Apr 21, 2025
Status verified date
Jul, 2026
Completion date
Aug 31, 2028
Anticipated
Primary completion date
Aug 31, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
177 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Supportive Care
Arms
experimental: Step Up
other: Usual Care Plus (UC+)
Interventions
Step Up
Usual Care Plus (UC+)
Primary outcome measure
Central contacts
Sarah Kelleher, PhD
sarah.kelleher@duke.eduLocations
Duke Cancer Institute
Recruiting
Durham, North Carolina, United States, 27705
Sponsor
Duke University
Last update posted
Jul 15, 2026
Last verified
Jul, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Duke University on 2026-07-15.